CHICAGO (GenomeWeb) – BC Platforms, a Swiss genomic data management company, announced today that it has raised $10 million in a Series B funding round. The Debiopharm Innovation Fund, of Lausanne, Switzerland, and Finnish private equity company Tesi led the investment.

BC Platforms said it plans on using the funding in part to add a clinical component this year to its existing software for genomic data management. The company has a goal of managing genomic and clinical data of at least 5 million people by 2020, drawn from biobanks around the world.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Two researchers have found that behavioral genetic defenses in criminal cases don't tend to affect outcomes, according to Popular Science.

Researchers report that while host genetics influence the oral microbiome, they don't appear to affect cavity-causing microbes, the Economist says.

Pandas' gut microbiomes change as what they eat changes with the seasons, writes Discover's Inkfish blog.

In PLOS this week: comparative genomic study of malaria-linked macaque parasite, search for apple root reference genes, and more.